(917) 310-3371
Buprenorphine
The active medication category used for opioid-use disorder treatment and craving/withdrawal stabilization.
Buprenorphine treatment in NYC and Long Island
Medication support for opioid-use disorder, Suboxone treatment, Sublocade review, fentanyl-aware timing, insurance questions, and ongoing recovery follow-up.
Buprenorphine is one of the FDA-approved medications used to treat opioid-use disorder. It can help reduce withdrawal symptoms and cravings when started and monitored correctly.
Medication decisions require clinical review. A medication that helps one person may be unsafe for another because of recent substance use, withdrawal timing, pregnancy, liver or kidney disease, seizure history, opioid exposure, psychiatric symptoms, current prescriptions, or overdose risk.
Timing matters with buprenorphine
Recent fentanyl or opioid use can affect the safest start strategy, so the first visit reviews symptoms before medication moves forward.
Buprenorphine, Suboxone, and Sublocade
Why timing matters
Buprenorphine can be very helpful, but it has to be started thoughtfully. If someone recently used fentanyl, heroin, oxycodone, hydrocodone, Percocet, Vicodin, codeine, OxyContin, or another opioid, the provider needs to understand timing, symptoms, prior buprenorphine experience, overdose history, and whether withdrawal has started.
Starting too early can make withdrawal feel abruptly worse. Waiting too long can leave someone uncomfortable, at risk of relapse, or unsafe. The first visit balances symptom relief with safety, especially when fentanyl exposure makes withdrawal timing less predictable.
How buprenorphine care works
1. Book a private visit
Choose telehealth or local care when appropriate, share urgent timing needs, and bring medication, insurance, and pharmacy information.
2. Meet your provider
Review opioid use, withdrawal symptoms, medical history, mental health, medication safety, and recovery goals without judgment.
3. Start a treatment plan
If eligible, medication can be planned with education, pharmacy coordination, follow-up timing, and safety guidance.
4. Keep support in place
Follow-up visits review cravings, side effects, dose stability, testing, relapse risk, counseling, and longer-term recovery needs.
What the provider reviews
Opioid pattern
Recent fentanyl, heroin, prescription opioid, or mixed substance use changes the start plan and follow-up timing.
Withdrawal and cravings
Symptoms help determine whether medication timing is safe and whether dose adjustment may be needed later.
Medical history
Pregnancy questions, liver disease, breathing problems, sedation risk, seizure history, pain needs, and current prescriptions all matter.
Recovery support
Work, family, transportation, housing, counseling, privacy, and pharmacy access can make the plan easier or harder to keep.
Pain pills and opioid-use disorder
Hydrocodone, Vicodin, Percocet, codeine, and OxyContin are opioid pain medications. They can be involved in opioid-use disorder, but they are not medications used to treat opioid-use disorder. Nao Medical's office-based opioid-use-disorder pathways include buprenorphine products and naltrexone/Vivitrol when clinically appropriate.
Suboxone, Sublocade, Brixadi, and Vivitrol
Suboxone
A daily buprenorphine-naloxone option that can support outpatient stabilization when clinically appropriate.
Sublocade
A monthly injectable buprenorphine option for eligible patients already stabilized on buprenorphine.
Vivitrol
Monthly injectable naltrexone that requires opioid-free planning before opioid relapse-prevention use.
Brixadi
Weekly or monthly extended-release buprenorphine may fit selected patients after evaluation, access coordination, and dose planning.
Stabilization, maintenance, and future tapering
Buprenorphine treatment is not one-size-fits-all. Early care often focuses on withdrawal relief, cravings, medication tolerance, overdose prevention, and getting through the first days without returning to unsafe opioid use. Once symptoms become more stable, follow-up can shift toward work routines, family trust, counseling, sleep, mood, and reducing situations that trigger relapse.
Some patients stay on medication for a long time because it keeps them safer and more functional. Others eventually ask about dose changes or tapering. That decision should be based on stability, overdose risk, support, prior relapse history, mental health, and timing rather than pressure or shame.
Follow-up rhythm that keeps treatment grounded
Early phase
Visits may be closer together while withdrawal symptoms, cravings, dose response, side effects, and pharmacy access are still changing.
Stabilization
Once symptoms are steadier, care can focus on counseling, work routines, family trust, sleep, mental health, and relapse prevention.
Maintenance
Longer-term care reviews medication fit, refill timing, testing needs, insurance changes, and whether injectable options make sense.
Change planning
Dose changes, missed doses, relapse, travel, surgery, pregnancy questions, or new medications should be discussed before the plan is altered.
When a higher level of care may be safer
Severe withdrawal
Vomiting, dehydration, confusion, uncontrolled symptoms, or medical instability may need emergency or inpatient care.
High overdose risk
Recent overdose, heavy fentanyl exposure, mixed sedative use, or loss of consciousness needs a stronger safety plan.
Psychiatric crisis
Suicidal thoughts, psychosis, severe agitation, or inability to stay safe needs urgent mental-health support.
Enhanced outpatient support
Patients can combine medication visits with counseling, recovery support, and closer follow-up when a more structured outpatient plan would help.
Local buprenorphine access
Bronx
174th Street
932 E 174th St, Bronx, NY 10460
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View local medication support Get directions
Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
View local medication support Get directions
Bronx
Bartow Mall
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View local medication support Get directions
Brooklyn
Crown Heights
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
View local medication support Get directions
Long Island
Hicksville
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View local medication support Get directions
Queens
Jackson Heights
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
Jamaica
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
Long Island City
30-07 36th Ave, Astoria, NY 11106
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View local medication support Get directions
Long Island
Mineola
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View local medication support Get directions
Manhattan
StuyTown
259 1st Ave, New York, NY 10003
A Manhattan access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View local medication support Get directions
Brooklyn
Williamsburg
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View local medication support Get directionsBuprenorphine FAQs
Buprenorphine is an FDA-approved medication for opioid-use disorder. It can reduce withdrawal symptoms and cravings when used under medical supervision.
Suboxone is a buprenorphine-naloxone product. Buprenorphine treatment is the broader medication category.
Yes. Sublocade is a monthly injectable buprenorphine option for eligible patients after buprenorphine tolerability and the appropriate transition plan are confirmed.
Sometimes, but timing depends on recent opioid use, withdrawal symptoms, fentanyl exposure, and clinical review.
Coverage varies by visit type, medication, pharmacy benefit, lab testing, counseling, and prior authorization. The team can verify the relevant benefits before treatment begins.
Precipitated withdrawal can happen if buprenorphine is started before the body is ready after recent opioid use. Timing is especially important after fentanyl exposure.
Buprenorphine can be part of evidence-based opioid-use disorder treatment for people exposed to fentanyl, but the start strategy may require careful timing and follow-up.
Sublocade may be considered for eligible patients after buprenorphine tolerability and the appropriate transition plan are confirmed. The provider reviews stability, dose history, coverage, and injection scheduling.
Buprenorphine can treat opioid-use disorder involving prescription opioids, but the visit must separate pain treatment needs from addiction treatment goals.
Medication can be central, but counseling, relapse planning, mental-health care, family support, and follow-up often improve stability.
Yes, many patients benefit from longer maintenance. Duration should be individualized rather than rushed because stopping too soon can increase relapse and overdose risk.
A taper may be considered when stability, supports, relapse risk, and timing are appropriate. It should be planned with a clinician rather than done abruptly.
Sedation, breathing problems, severe constipation, allergic symptoms, confusion, worsening mood, or any impairment should be reported promptly or treated urgently when severe.
Mixing sedatives can increase overdose and breathing risk. Alcohol, benzodiazepines, sleep medications, and other sedating drugs must be discussed honestly.
The provider may adjust follow-up, review counseling, consider injectable options, coordinate mental-health care, or refer to a higher level of care when needed.
Many patients continue work, school, and family routines during treatment, but sedation, driving risk, safety-sensitive duties, and side effects should be reviewed.
Family can support follow-up, naloxone access, transportation, and nonjudgmental encouragement while respecting patient privacy and consent.
Related treatment paths
Compare medication, visit, and follow-up options, then choose the care path that fits your current needs.
Suboxone treatment
Buprenorphine-naloxone evaluation, medication planning, and ongoing follow-up.
Online Suboxone treatment
Telehealth evaluation when appropriate, with local clinic support when an in-person step is needed.
Same-day Suboxone evaluation
Fast assessment without promising that medication can or should start before timing and safety are reviewed.
Kratom dependence treatment
Assessment of withdrawal, product type, 7-OH exposure, opioid overlap, and appropriate next steps.
Sublocade injections
Monthly extended-release buprenorphine evaluation, access coordination, and in-clinic administration planning.
Brixadi injections
Weekly or monthly extended-release buprenorphine evaluation, coverage coordination, and treatment planning.
Clinical sources
These public clinical and regulatory sources were checked on August 1, 2026. They support the general information and do not replace an individual medical evaluation.
SAMHSA: Buprenorphine
Medication overview, benefits, risks, and treatment resources.
SAMHSA: Quick Start Guide
Clinical assessment, withdrawal timing, induction, and follow-up guidance.
New York OASAS: Medications for OUD
New York guidance on buprenorphine and other evidence-based medications.
Focused care or a more supported outpatient program
Nao Medical operates a New York State OASAS-certified outpatient addiction treatment program. The first visit can focus on the immediate clinical question and medication planning when relevant, or the care plan can include counseling, recovery support, and closer follow-up when that is wanted or clinically recommended.
Focused clinical visits
Patients can request a private evaluation centered on the immediate concern, prescribing or injection planning when applicable, monitoring, and practical next steps. Medication is never automatic; eligibility and safety still require clinician review.
Counseling is available
Patients who want more support can add counseling, relapse-prevention work, care coordination, and recovery follow-up through the outpatient addiction program.
Confidential intake first
After scheduling, complete the confidential addiction intake form when it is sent. It helps the team review current substance use, prior treatment, medications, insurance, and the safest visit type.
Nao Medical accepts Medicaid and many major insurance plans, including Medicare, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare and UnitedHealthcare Community Plan, EmblemHealth, Aetna, Cigna, and Blue Cross Blue Shield. Coverage varies by visit, medication, pharmacy benefit, testing, counseling, and prior authorization. Review addiction-treatment insurance support.
Health information notice
General information only. The information here is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.